August 30, 2014 4:29 PM ET

Diversified Consumer Services

Company Overview of University of Cambridge

Company Overview

University of Cambridge is an educational institution that offers graduate, postgraduate, and research programs in the field of science, business, social sciences, and law. It offers courses in history, environmental studies, psychology, sociology, zoology, oriental studies, business administration, philosophy, biochemistry, music, engineering, geology, architecture, international relations, and medicine. The institution was founded in 1209 and is based in Cambridge, United Kingdom.

The Old Schools

Trinity Lane

Cambridge,  CB2 1TN

United Kingdom

Founded in 1209


44 1223 332290


44 1223 339669

Key Executives for University of Cambridge

Vice Chancellor
Regius Professor of Physic
Master of Pembroke College
Age: 69
Head of Institute for Stem Cell Biology
Compensation as of Fiscal Year 2014.

University of Cambridge Key Developments

University of Cambridge Presents at 4th Annual Biobanking, Jun-24-2014 11:00 AM

University of Cambridge Presents at 4th Annual Biobanking, Jun-24-2014 11:00 AM. Venue: Holiday Inn Regents Park, Carburton Street, Londong, United Kingdom. Speakers: Matt Sims, Head of Research Operations, MRC Epidemiology.

MedImmune Signs Three-Year Oncology Research Collaboration with University of Cambridge

AstraZeneca's global biologics R&D unit, has signed a three-year oncology research collaboration with the University of Cambridge. It was reported that the collaboration is aimed at advancing cancer research by using imaging technologies to measure key biologic changes within growing tumours. MedImmune will contribute both funding and a post-doctoral scientist to work within the laboratory of professor Kevin Brindle at the University of Cambridge in the area of tumour targeted therapies. The company stated that tumour targeted therapies includes antibodies that are armed to kill tumour cells, including antibody-drug conjugates that selectively aim powerful drugs at cancer cells.

University of Cambridge, Genomics England Ltd., and Illumina Collaborate to Sequence 10,000 Whole Human Genomes for National Health Service Patients

University of Cambridge, Genomics England Ltd., and Illumina Inc. announced the start of a three-year project that will sequence 10,000 whole genomes of children and adults with rare genetic diseases. The project represents a pilot for Genomics England Ltd., which will provide 2,000 samples, and marks the beginning of the national endeavor to sequence 100,000 genomes in the UK National Health Service (NHS).

Similar Private Companies By Industry

Company Name Region
Tyre Sales (Birmingham) Limited Europe
Nationwide Crash Repair Centres Ltd Europe
Kwik-Fit (GB) Limited Europe
Wash and Press Centre Limited Europe
Jones Day Care Nurseries Limited Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact University of Cambridge, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at